France bleu26d
Addiction aux jeux et au sexe : la descente aux enfers des victimes de médicaments contre la maladie de Parkinson
Cela signifie que dès 2006, GSK est au courant que des recherches sont menées pour découvrir si le Requip pourrait devenir une sorte de nouveau Viagra ... de voir le logo de GSK notamment ...
Radio France25d
Addiction aux jeux, au sexe et pulsions violentes : la face obscure des médicaments anti-parkinsoniens
Cela signifie que dès 2006, GSK est au courant que des recherches sont menées pour découvrir si le Requip pourrait devenir une sorte de nouveau Viagra ... A l’époque, il s’étonne de voir le logo de ...
GSK initiated with an Equal Weight at Morgan Stanley
Morgan Stanley initiated coverage of GSK (GSK) with an Equal Weight rating and 1,450 GBp price target The shares trade at an inexpensive ...
GSK launches $2.5 billion buyback, lifts sales target after stellar fourth quarter
GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...
GSK price target raised to 1,500 GBp from 1,440 GBp at JPMorgan
JPMorgan raised the firm’s price target on GSK (GSK) to 1,500 GBp from 1,440 GBp and keeps an Underweight rating on the shares.Maximize Your ...
Seeking Alpha7d
GSK outlines 2025 growth driven by specialty medicines and new product launches
CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...
Insider Monkey6d
Why GSK plc (GSK) Went Up on Wednesday
In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...
The Motley Fool UK5d
Down 15% and with a P/E below 9! Is the GSK share price still in deep value territory?
Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run. Is there scope for more growth? The content of this article is ...
London Evening Standard7d
GSK lifts long-term sales targets on new drug pipeline
It came as the boss of the London-listed firm cheered an ‘excellent’ performance in 2024. GSK has increased its long-term sales guidance amid hopes for a boost from new speciality medicines ...
Yahoo Finance28d
JNJ, GSK, LLY Announce M&A Deals at JP Morgan Conference
Eli Lilly made a $2.5 billion deal for a breast cancer drug; GSK reached a $1 billion-plus deal for IDRx. The announcements suggest a potential rebound in M&A deals in the healthcare sector for 2025.
Benzinga.com28d
GSK Highlights New Approvals, Vaccine Momentum At JPMorgan Healthcare Conference
Brand New Membership Level: Benzinga Trade Alerts GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from existing assets. At the JPMorgan Healthcare ...
FierceBiotech28d
JPM25: GSK’s CSO shares science strategy behind deal-heavy year
Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...